Singapore markets close in 7 hours 17 minutes

Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
0.8421-0.0490 (-5.50%)
At close: 04:00PM EDT
0.8599 +0.02 (+2.11%)
After hours: 08:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.8911
Open0.8846
Bid0.8505 x 1400
Ask0.8580 x 4000
Day's range0.7907 - 0.9192
52-week range0.7400 - 2.5450
Volume86,069,972
Avg. volume28,406,290
Market cap1.855B
Beta (5Y monthly)1.36
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • PR Newswire

    Ginkgo Bioworks Announces Nomination of Myrtle Potter and Ross Fubini to Board of Directors

    Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the nomination of Myrtle Potter and Ross Fubini for election as independent directors at Ginkgo's upcoming annual meeting, scheduled to be held on June 13, 2024.

  • PR Newswire

    Il Granaio delle Idee and Ginkgo Bioworks Announce Strategic Collaboration to Optimize Sourdough Strains for Bakery Products

    Il Granaio delle Idee (IGDI), an innovative international developer and provider of clean label baking ingredients, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new collaboration. IGDI has identified a new sourdough bakery strain that can improve the flavor and aroma profile of baked goods via its starter culture product, Pater®. This collaboration will leverage Ginkgo's Adaptive Laboratory Evolution (ALE) technol

  • PR Newswire

    Ginkgo Bioworks Announces Acquisition of AgBiome's Platform Assets

    Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of AgBiome's platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline. These assets will be integrated into Ginkgo Ag Biologicals Services, established with the acquisition of a Bayer agricultural biologicals R&D fa